  | Nguyen, T. H., Limpens, M., Bouhmidi, S., Paprzycki, L., Legrand, A., Decleves, A.-E., Heher, P., Belayew, A., Banerji, C. R. S., Zammit, P. S., & Tassin, A. (15 March 2024). The DUX4-HIF1α Axis in Murine and Human Muscle Cells: A Link More Complex Than Expected. International Journal of Molecular Sciences, 25 (332). doi:10.20944/preprints202211.0532.v2  Peer Reviewed verified by ORBi |
 | Nguyen, T.-H., Paprzycki, L., Legrand, A., Decleves, A.-E., Heher, P., Limpens, M., Belayew, A., Banerji, C. R. S., Zammit, P. S., & Tassin, A. (16 December 2023). Hypoxia enhances human myoblast differentiation: involvement of HIF1α and impact of DUX4, the FSHD causal gene. Skeletal Muscle, 13 (1), 21. doi:10.1186/s13395-023-00330-2 Peer Reviewed verified by ORBi |
 | Claus, C., Slavin, M., Bah, K., Lancelot, C., Lassche, S., Fievet, M., Greco, A., Kusters, B., Decleves, A.-E., Van Engelen, B., Belayew, A., Kalisman, N., & Coppée, F. (09 June 2023). DUX4 and DUX4c directly interact with C1qBP in FSHD regenerating myofibers [Paper presentation]. International Research Congress. |
 | Claus, C., Slavin, M., Ansseau, E., Lancelot, C., Bah, K., Lassche, S., Fievet, M., Greco, A., Tomaiuolo, S., Tassin, A., Dudome, V., Kusters, B., Decleves, A.-E., Laoudj-Chenivesse, D., van Engelen, B. G. M., Nonclercq, D., Belayew, A., Kalisman, N., & Coppée, F. (07 March 2023). The double homeodomain protein DUX4c is associated with regenerating muscle fibers and RNA-binding proteins. Skeletal Muscle, 13 (1), 5. doi:10.1186/s13395-022-00310-y Peer Reviewed verified by ORBi |
Limpens, M., Derenne, A., Burtea, C., Laurent, S., Legrand, A., Wilton, S., Belayew, A., Coppée, F., Decleves, A.-E., & Tassin, A. (2023). Selection of peptides for a muscle-targeted delivery of ASO directed against DUX4 mRNAs through complementary approaches in silico, in vitro and in vivo [Paper presentation]. Physphar Spring meeting (2023), Brussels, Belgium. Editorial reviewed |
Nguyen, T. H., Legrand, A., Decleves, A.-E., Heher, P., Belayew, A., Banerji, C. R. S., Zammit, P. S., & Tassin, A. (12 September 2022). Relationship between DUX4 and Hypoxia-Inducible Factor (HIF1α) in human and murine muscle cells vitro and in vivo [Poster presentation]. International Myology Congress. Editorial reviewed |
 | Nguyen, T. H., Legrand, A., Decleves, A.-E., Heher, P., Belayew, A., Banerji, R. S. C., Zammit, P., & Tassin, A. (16 June 2022). Relationship between DUX4 and Hypoxia-Inducible Factor (HIF1α) in human and murine muscle cells vitro and in vivo [Poster presentation]. FSHD Society international research congress 2022. Editorial reviewed |
 | Nguyen, T. H., Conotte, S., Belayew, A., Decleves, A.-E., Legrand, A., & Tassin, A. (05 July 2021). Hypoxia and Hypoxia-Inducible Factor Signaling in Muscular Dystrophies: Cause and Consequences. International Journal of Molecular Sciences, 22 (13). Peer Reviewed verified by ORBi |
Nachtergael, A., Lanterbecq, D., Spanoghe, M., Belayew, A., & Duez, P. (12 June 2021). Effects of chemopreventive natural compounds on the accuracy of 8-oxo-7,8-dihydro-2'-deoxyguanosine translesion synthesis. Planta Medica, 87 (10/11), 868-878. Peer Reviewed verified by ORBi |
 | Derenne, A., Tassin, A., Nguyen, T. H., DeRoeck, E., Jenart, V., Ansseau, E., Belayew, A., Coppée, F., Decleves, A.-E., & Legrand, A. (2020). Induction of a local muscular dystrophy using electroporation in vivo: an easy tool for screening therapeutics. Scientific Reports. Peer reviewed |
 | Baroni, A., Neaga, I., Delbosc, N., Wells, M., Verdy, L., Ansseau, E., Vanden Eynde, J.-J., Belayew, A., Bodoki, E., Oprean, R., Hambye, S., & Blankert, B. (25 September 2019). Bioactive Aliphatic Polycarbonates Carrying Guanidinium Functions: An Innovative Approach for Myotonic Dystrophy Type 1 Therapy. ACS Omega, 4 (19), 18126 - 18135. doi:10.1021/acsomega.9b02034 Peer reviewed |
 | Derenne, A., Kouakou, C., Belayew, A., Decleves, A.-E., Tassin, A., Burtea, C., & Coppée, F. (08 March 2019). Development of peptides for specific skeletal muscle targeted drug delivery [Poster presentation]. 2019 Advances in Skeletal Muscle Biology in Health and Disease, University of Florida, United States - Florida. Editorial reviewed |
Panamarova, M., Tassin, A., Belayew, A., & Zammit, P. (25 June 2018). Mapping D4Z4 - driven expression profile and dynamics in FSHD [Paper presentation]. New Directions in Biology and Disease of Skeletal Muscle Conference, New Orleans, United States - Louisiana. Editorial reviewed |
Neaga, I.-O., Hambye, S., Bodoki, E., Palmieri, C., Ansseau, E., Belayew, A., Oprean, R., & Blankert, B. (11 May 2018). Affinity capillary electrophoresis for identification of active drug candidates in myotonic dystrophy type 1. Analytical and Bioanalytical Chemistry, 410, 4495-4507. Peer Reviewed verified by ORBi |
 | Vanderplanck, C., Tassin, A., Ansseau, E., Charron, S., Wauters, A., Lancelot, C., Vancutsem, K., Laoudj Chevinesse, D., Belayew, A., & Coppée, F. (12 January 2018). 'Overexpression of the double homeodomain protein DUX4c interferes with myofibrillogenesis and induces clustering of myonuclei'. Skeletal Muscle, 8 (2). doi:10.1186/s13395-017-0148-4 Peer reviewed |
 | Ansseau, E., Sciot, M., Goudji, C., Castella, S., Larcher, J.-C., Belayew, A., & Coppée, F. (2017). FSHD and OPMD: Deregulation of IGF2BP1-mRNP components during the differentiation of FSHD muscle cells [Paper presentation]. 22nd International Congress of the Word Muscle Society, Saint Malo, France. |
 | Panamarova, M., Tassin, A., Moyle, L., Belayew, A., & Zammit, P. (2017). Generation of a mouse model of FSHD to reveal the DUX4 expression profile and dynamics [Paper presentation]. 10th Neuromuscular Translational Research Conference, London, United Kingdom. |
Derenne, A., De Roeck, E., Tassin, A., Coppée, F., Belayew, A., Decleves, A.-E., & Legrand, A. (07 March 2017). DUX4 surexpression and silencing in a murine model [Poster presentation]. Mardi des Chercheurs (MdC2017), Mons, Belgium. |
 | Ansseau, E., Vanderplanck, C., Wauters, A., Harper, S. Q., Coppée, F., & Belayew, A. (03 March 2017). Oligonucleotides Used to Target the DUX4 mRNA as Therapeutic Approaches in FaciosScapuloHumeral Muscular Dystrophy (FSHD). Genes, 8 (3), 93. doi:10.3390/genes8030093 Peer Reviewed verified by ORBi |
 | Vancutsem, K., Charron, S., Belayew, A., & Coppée, F. (16 November 2016). Study of atrophy in Facioscapulohumeral muscular dystrophy (FSHD) [Poster presentation]. Bioforum, Liège Ulg , Unknown/unspecified. |
 | Ansseau, E., Lancelot, C., Wauters, A., Vanderplanck, C., Belayew, A., & Coppée, F. (10 November 2016). Transcription factors DUX4 and DUX4c associate with mRNP granules in the cytoplasm of fusing myoblasts: a new function in translation regulation? [Poster presentation]. FSH Society, Boston, United States - Massachusetts. |
 | Ansseau, E., Lancelot, C., Belayew, A., & Coppée, F. (04 October 2016). Transcription factors DUX4 and DUX4c associate with mRNP granules in the cytoplasm of fusing myoblasts: a new function in translation regulation? [Poster presentation]. 21st International WMS Congress, Granada, Spain. |
P, D., Kiseleva, E., Kharchenko, O., Ivashkin, E., Pichugin, A., Dessen, P., Robert, T., Coppée, F., Belayew, A., Camac, G., Laoudj Chevinesse, D., Lipinski, M., Vasiliev, A., & Vassetzky, Y. (04 October 2016). Dux4 controls migration of mesenchymal stem cells through the Cxcr4-Sdf1 axis. Oncotarget, 7 (40), 65090-65108. doi:10.18632/oncotarget.11368 Peer reviewed |
 | Ansseau, E., O, J., Lancelot, C., Tassin, A., Matteoti, C., Yip, C., Liu, J., Leroy, B., Hubeau, C., Gerbaux, C., Cloet, S., Wauters, A., Zorbo, S., Meyer, P., Pirson, I., Laoudj Chevinesse, D., Wattiez, R., Harper, S., Belayew, A., & Coppée, F. (14 March 2016). The translocation of DUX4 and DUX4c during myoblast differentiation allows their association with nucleo-cytoplasmic proteins associated with mRNP granules [Poster presentation]. International Congress Of Myology, Lyon, France. |
De La Kethulle De Ryove, L., Ansseau, E., Nachtegael, C., Pieters, K., Vanderplanck, C., Geens, M., Sermon, K., Wilton, S., Coppée, F., Lagneaux, L., & Belayew, A. (14 March 2016). The Role of D4Z4-Encoded Proteins in the Osteogenic Differentiation of Mesenchymal Stromal Cells Isolated from Bone Marrow [Poster presentation]. 5th International Congress of Myology, Lyon, France. |
 | Vanderplanck, C., Tassin, A., Ansseau, E., Lancelot, C., Derenne, A., Conotte, S., Dudome, V., Leroy, B., Wilton D., S., Laoudj-Chenivesse, D., Wattiez, R., Legrand, A., Belayew, A., & Coppée, F. (14 March 2016). 'Antisense strategies targeting DUX4 and DUX4c for the treatment of Facioscapulohumeral muscular dystrophy.' [Poster presentation]. 5th International Congress of Myology, Lyon, France. |
Ansseau, E., Eidal, J., Lancelot, C., Tassin, A., Matteotti, C., Yip, C., Liu, J., Leroy, B., Hubeau, C., Gerbaux, C., Cloet, S., Wauters, A., Zorbo, S., Meyer, P., Pirson, I., Laoudj-Chenivesse, D., Wattiez, R., Harper, S. Q., Belayew, A., & Coppée, F. (2016). Homologous transcription factors DUX4 and DUX4c associate with cytoplasmic proteins during muscle differentiation. PLoS ONE. Peer reviewed |
Panamarova, M., Tassin, A., Moyle, L., Belayew, A., & Zammit, P. (05 January 2016). Generation of a mouse model of FSHD to reveal the DUX4 expression profile and dynamics [Paper presentation]. UK Neuromuscular Translational Research Conference, Oxford, United Kingdom. Editorial reviewed |
Belayew, A. (09 December 2015). Contribution of DUX4 and DUX4c to the molecular mechanism of FSHD [Paper presentation]. London Myology Forum, Londres, United Kingdom. |
Belayew, A. (26 October 2015). Le B. A. BA sur la FSHD [Paper presentation]. Meeting des Amis FSH, Agde , France. |
Belayew, A. (25 October 2015). La recherche sur la FSHD dans le monde [Paper presentation]. Meeting des Amis FSH, Agde , France. |
  | Dhont, L., Mascaux, C., & Belayew, A. (15 October 2015). The helicase-like transcription factor (HLTF) in cancer: loss of function or oncomorphic conversion of a tumor suppressor? Cellular and Molecular Life Sciences, 73, 129-145. Peer Reviewed verified by ORBi |
Ansseau, E., Eidahl, J. O., Lancelot, C., Tassin, A., Matteoti, C., Yip, C., Liu, J., Leroy, B., Hubeau, C., Gerbaux, C., Cloet, S., Wauters, A., Zorbo, S., Meyer, P., Pirson, I., Laoudj-Chenivesse, D., Wattiez, R., Harper, S. Q., Belayew, A., & Coppée, F. (06 October 2015). The translocation of DUX4 and DUX4c during myoblast differentiation allows their association with nucleo-cytoplasmic proteins associated with mRNP granules [Paper presentation]. FSH society, Boston, United States - Massachusetts. |
De La Kethulle De Ryhove, L., Ansseau, E., Nachtegael, C., Pieters, K., Vanderplanck, C., Geens, M., Sermon, K., Wilton D., S., Coppée, F., Lagneaux, L., & Belayew, A. (06 October 2015). The Role of D4Z4-Encoded Proteins in the Osteogenic Differentiation of Mesenchymal Stromal Cells Isolated from Bone Marrow [Paper presentation]. FSH Society, Boston, United States - Massachusetts. |
Ansseau, E., Eidahl, J. O., Lancelot, C., Tassin, A., Matteoti, C., Yip, C., Liu, J., Leroy, B., Hubeau, C., Gerbaux, C., Cloet, S., Wauters, A., Zorbo, S., Meyer, P., Pirson, I., Laoudj-Chenivesse, D., Wattiez, R., Harper, S. Q., Belayew, A., & Coppée, F. (04 October 2015). Unexpected location of DUX4/4c transcription factors in the cytoplasm suggests a role in mRNP granules and translation regulation [Poster presentation]. International World Muscle Society Congress, Brighton, United Kingdom. |
Vanderplanck, C., Tassin, A., Ansseau, E., Lancelot, C., Derenne, A., Conotte, S., Dudome, V., Leroy, B., Wilton D., S., Laoudj-Chenivesse, D., Wattiez, R., Legrand, A., Belayew, A., & Coppée, F. (2015). Antisense strategies targeting DUX4 and DUX4c for the treatment of Facioscapulohumeral muscular dystrophy [Paper presentation]. International World Muscle Society congress, Brighton, United Kingdom. |
Poivre, M., Nachtergael, A., Atsapkina, A., Kryshen, K., Belayew, A., & Shikov, A. (24 September 2015). Preliminary assessment of the cytotoxicity and genotoxicity of an association Aristolochia baetica - Magnolia officinalis [Paper presentation]. Applied Biotechnology in Africa, Kigali, Rwanda. |
Poivre, M., Nachtergael, A., Atsapkina, A., Kryshen, K., Belayew, A., Shikov, A., & Duez, P. (24 September 2015). 'Preliminary assessment of the cytotoxicity and genotoxicity of an association Aristolochia baetica - Magnolia officinalis' [Poster presentation]. Applied Biotechnology in Africa, Kigali, Rwanda. |
 | Vancutsem, K., Charron, S., Belayew, A., & Coppée, F. (23 September 2015). Study of atrophy in Facioscapulohumeralmuscular dystrophy (FSHD) [Poster presentation]. EMBO workshop : Molecular Mechanisms of muscle growth and wasting in health and disease, Ascona , Unknown/unspecified. |
Lancelot, C., Mascolo, C., Nonclercq, D., Carnac, G., Laoudj-Chenivesse, D., Coppée, F., & Belayew, A. (22 September 2015). How does fibrosis in FSHD muscle contribute to the lack of muscle regeneration ? [Poster presentation]. EMBO workshop : Molecular Mechanisms of muscle growth and wasting in health and disease, Ascona , Unknown/unspecified. |
 | Wauters, A., Tassin, A., Leroy, B., Laval, S., Wattiez, R., & Belayew, A. (21 September 2015). Caveolar proteins : putative FSHD biomarkers [Poster presentation]. EMBO workshop : Molecular Mechanisms of muscle growth and wasting in health and disease, Ascona , Unknown/unspecified. |
 | Nachtergael, A., Poivre, M., Belayew, A., & Duez, P. (13 August 2015). In vitro genotoxicity tests point to an unexpected and harmful effect of a Magnolia and Aristolochia association. Journal of Ethnopharmacology, 174, 178-186. doi:10.1016/j.jep.2015.07.045 Peer Reviewed verified by ORBi |
De La Kethulle De Ryhove, L., Ansseau, E., Nachtegael, C., Pieters, K., Vanderplanck, C., Geens, M., Sermon, K., Wilton D., S., Coppée, F., Lagneaux, L., & Belayew, A. (20 July 2015). The Role of D4Z4-Encoded Proteins in the Osteogenic Differentiation of Mesenchymal Stromal Cells Isolated from Bone Marrow. Stem Cells and Development, 24 (22), 2674-86. doi:10.1089/scd.2014.0575 Peer Reviewed verified by ORBi |
Nachtergael, A., Lanterbecq, D., Gadenne, M., Belayew, A., & Duez, P. (12 July 2015). Translesion synthesis modulators from natural products :: Analytical development, validation and applications [Poster presentation]. Joint meeting of the GP-TCM Research Association, The TCM Chemistry Specialty Committee and the TCM Pharmaceutical Analysis Specialty Committee of the World Federation of Chinese Medicine Societies, Mons, Belgium. |
Poivre, M., Nachtergael, A., Belayew, A., & Duez, P. (12 July 2015). Preliminary assessment of the cytotoxicity and genotoxicity of an association Aristolochia - Magnolia [Poster presentation]. Joint meeting of the GP-TCM Research Association, The TCM Chemistry Specialty Committee and the TCM Pharmaceutical Analysis Specialty Committee of the World Federation of Chinese Medicine Societies, Mons, Belgium. |
Poivre, M., Nachtergael, A., Belayew, A., & Duez, P. (22 May 2015). A preliminary assessment of traditional Chinese herbs cytotoxicity and genotoxicity [Poster presentation]. Journée d'études UMHAP - from lab to bedside, UMONS, Belgium. |
Vanderplanck, C., Tassin, A., Ansseau, E., Lancelot, C., Derenne, A., Conotte, S., Dudome, V., Leroy, B., Wilton D., S., Laoudj-Chenivesse, D., Wattiez, R., Legrand, A., Belayew, A., & Coppée, F. (22 May 2015). Antisense strategies targeting DUX4 and DUX4c for the treatment of Facioscapulohumeral muscular dystrophy [Poster presentation]. Journée UMHAP from lab to bedside, Mons, Belgium. |
Vanderplanck, C., Tassin, A., Ansseau, E., Lancelot, C., Derenne, A., Conotte, S., Dudome, V., Leroy, B., Wilton D., S., Laoudj-Chenivesse, D., Wattiez, R., Legrand, A., Belayew, A., & Coppée, F. (17 April 2015). Antisense strategies targeting DUX4 and DUX4c for the treatment of facioscapulohumeral muscular dystrophy (FSHD [Poster presentation]. Novel Therapies for monogennic diseases, Paris, France. |
Vanderplanck, C., Tassin, A., Ansseau, E., Lancelot, C., Derenne, A., Conotte, S., Dudome, V., Leroy, B., Wilton D., S., Laoudj-Chenivesse, D., Wattiez, R., Legrand, A., Belayew, A., & Coppée, F. (15 April 2015). Antisense strategies targeting DUX4 and DUX4c for the treatment of Facioscapulohumeral muscular dystrophy [Poster presentation]. symposium de thérapie génique du Collège de France, Paris, France. |
Belayew, A. (04 April 2015). DUX4 au coeur de la FSHD [Paper presentation]. AMIS FSH - Rencontre de printemps, Mons, Belgium. |
 | Vancutsem, K., Charron, S., Belayew, A., & Coppée, F. (10 March 2015). Study of atrophy in Facioscapulohumeralmuscular dystrophy (FSHD) [Poster presentation]. 8ème édition de la Matinée des Chercheurs 2015 (MdC2015), Mons, Belgium. |
 | Wauters, A., Tassin, A., Leroy, B., Laval, S., Wattiez, R., Coppée, F., & Belayew, A. (10 March 2015). Membrane proteins : putative FSHD biomarkers [Poster presentation]. 8ème édition de la Matinée de Chercheurs, Mons, Belgium. |
Poivre, M., Nachtergael, A., Belayew, A., & Duez, P. (10 March 2015). « Cytotoxicity and genotoxicity assessment of traditional Chinese herbal extracts » [Poster presentation]. La matinée des chercheurs, Mons, Belgium. |
Ansseau, E., Domire, J. S., Wallace, L. M., Eidahl, J. O., Guckes, S. M., Giesige, C. R., Pyne, N. K., Belayew, A., & Harper, S. Q. (2015). Aberrant Splicing in Transgenes Containing Introns, Exons, and V5 Epitopes: Lessons from Developing an FSHD Mouse Model Expressing a D4Z4 Repeat with Flanking Genomic Sequences. PLoS ONE. Peer reviewed |
De La Kethulle De Ryhove, L., Ansseau, E., Nachtegael, C., Pieters, K., Vanderplanck, C., Geens, M., Sermon, K., Wilton D., S., Coppée, F., Lagneaux, L., & Belayew, A. (11 February 2015). The Role of D4Z4-Encoded Proteins in the Osteogenic Differentiation of Mesenchymal Stromal Cells Isolated from Bone Marrow [Poster presentation]. Télévie's Research Seminar, ULB-Erasme, Belgium. |
 | Dhont, L., Pintilie, M., Kaufman, E., Navab, R., Tam, S., Shepherd, F., Burny, A., Belayew, A., Tsao, M.-S., & Mascaux, C. (11 February 2015). Helicase-like Transcription Factor expression in Non Small Cell Lung Cancer (NSCLC) is associate with a poor prognosis [Poster presentation]. Télévie's Research Seminar, ULB-Erasme, Belgium. |
Lancelot, C., Tassin, A., Legrand, A., & Belayew, A. (2014). Interview radio et article internet - Le téléthon soutient aussi les chercheurs belges -. |
 | Wauters, A., Tassin, A., Leroy, B., Laval, S., Wattiez, R., Coppée, F., & Belayew, A. (19 October 2014). Membrane proteins: putative FSHD biomarkers? [Poster presentation]. FSH Society international research consortium and research planning meeting, San Diego, United States - California. |
 | Charron, S., Vancutsem, K., Vanderplanck, C., Lancelot, C., Carnac, G., Laoudj-Chenivesse, D., Belayew, A., & Coppée, F. (17 October 2014). WNT pathway alterations in FSHD [Poster presentation]. FSH Society international research consortium and research planning meeting, San Diego, United States - California. |
 | Ansseau, E., Matteoti, C., Tassin, A., Lancelot, C., Leroy, B., Hubeau, C., Nachtegael, C., Gerbaux, C., Zorbo, S., Cloet, S., Yip, C., Meyer, P., Carnac, G., Laoudj-Chenivesse, D., Wattiez, R., Belayew, A., & Coppée, F. (17 October 2014). Unexpected role for DUX transcription factors into the cytoplasm [Paper presentation]. International Research Consortium & Research Planning Meetings, San Diego, United States - California. |
Derenne, A., Tassin, A., Conotte, S., Coppée, F., Belayew, A., & Legrand, A. (17 October 2014). Comparison of two methods of naked DNA delivery in mice: which one is the most appropriate in the FSHD context? [Poster presentation]. FSH Society international research consortium and research planning meeting, San Diego, United States - California. |
Nachtergael, A., Poivre, M., Belayew, A., & Duez, P. (18 July 2014). A preliminary assessment of traditional Chinese herbs cytotoxicity and genotoxicity [Poster presentation]. The 3rd Annual Meeting of the GP-TCM Research Association and the 5th Annual Conference of the Specialty Committee of TCM Pharmaceutical Analysis of WFCMS, Nanjing, China. |
Vancutsem, K., Charron, S., Belayew, A., & Coppée, F. (08 July 2014). Study of atrophy in Facioscapulohumeral muscular dystrophy (FSHD) [Poster presentation]. ICNMD 13th International Congress in NeuroMuscular Diseases, Nice, France. |
 | Wauters, A., Tassin, A., Leroy, B., Laval, S., Coppée, F., Wattiez, R., & Belayew, A. (08 July 2014). Membrane proteins : putative FSHD biomarkers? [Poster presentation]. ICNMD 13th International Congress in NeuroMuscular Diseases, Nice, France. |
Lancelot, C., & Belayew, A. (08 July 2014). Development of fibrosis in FSHD muscle [Poster presentation]. ICNMD 13th International Congress in NeuroMuscular Diseases, Nice, France. |
 | Arcolia, V., Paci, P., Dhont, L., Chantrain, G., Sirtaine, N., Decaestecker, C., Remmelink, M., Belayew, A., & Saussez, S. (08 July 2014). Helicase-like Transcription Factor: a new marker of well-differentiated thyroid cancers. BMC Cancer, 14, 492-504. Peer reviewed |
Lancelot, C., Ansseau, E., Tassin, A., Matteoti, C., Leroy, B., Gerbaux, C., Zorbo, S., Cloet, S., Yip, C., Laoudj-Chenivesse, D., Wattiez, R., Belayew, A., & Coppée, F. (06 July 2014). Study of the double homeodomain DUX protein partners: focus on the interaction with desmin [Paper presentation]. IF-NMD Workshop Nice 2014 - Satellite Workshop to ICNMD, Nice, France. |
Tassin, A., Ansseau, E., Matteotti, C., Lancelot, C., Leroy, B., Gerbaux, C., Zorbo, S., Cloet, S., Yip, C., Laoudj-Chenivesse, D., Wattiez, R., Belayew, A., & Coppée, F. (14 May 2014). Study of the double homeodomain DUX protein partners highlights DUX4c involvement in human muscle regeneration [Paper presentation]. EMBO Conference : Molecular Biology of Muscle Development and Regeneration, Acaya-Lecce, Italy. Editorial reviewed |
Charron, S., Vancutsem, K., Vanderplanck, C., Lancelot, C., Laoudj-Chenivesse, D., Belayew, A., & Coppée, F. (14 May 2014). WNT pathway alterations in FSHD [Poster presentation]. EMBO Conference : Molecular Biology of Muscle Development and Regeneration, Acaya-Lecce, Italy. |
 | Charles, C., Nachtergael, A., Ouedraogo, M., Belayew, A., & Duez, P. (2014). Effects of chemopreventive natural products on non-homologous end-joining DNA double-strand break repair. Mutation Research - Genetic Toxicology and Environmental Mutagenesis, (768), 33-41. doi:10.1016/j.mrgentox.2014.04.014 Peer Reviewed verified by ORBi |
De La Kethulle De Ryhove, L., Ansseau, E., Geens, M., Coppée, F., Sermon, K., Lagneaux, L., & Belayew, A. (2014). DUX4 expression during Osteogenic Differentiation in MSCs [Paper presentation]. 20th ISCT Annual Meeting (International Society Cellular Therapy) 2014, Palais des Congrès, Paris, France. |
De La Kethulle De Ryhove, L., Ansseau, E., Geens, M., Coppée, F., Sermon, K., Lagneaux, L., & Belayew, A. (25 April 2014). DUX4 expression during Osteogenic Differentiation in MSCs [Poster presentation]. 20th ISCT Annual Meeting (International Society Cellular Therapy) 2014, Palais des Congrès, Paris, France. |
 | Dhont, L., Di Stefano, A., Szucs, A., Abdulsater, F., Bar, I., Delrée, P., & Belayew, A. (05 April 2014). Helicase-like Transcription Factor (HLTF) expression and gene methylation in FFPE colon tumors [Poster presentation]. American Association of Cancer Research, San Diego , United States - California. |
De La Kethulle De Ryhove, L., Ansseau, E., & Belayew, A. (2014). Mise à jour de la séquence AF117.653 (Homo sapiens double homeobox protein genes, complete cds). |
Nachtergael, A., Belayew, A., & Duez, P. (2014). Pyrosequencing for the quantitative assessment of 8-oxodG bypass DNA synthesis. DNA Repair, (22), 147-152. Peer Reviewed verified by ORBi |
Nachtergael, A., Charles, C., Spanoghe, M., Belayew, A., & Duez, P. (06 December 2013). DNA translesion synthesis modulation by natural products» [Poster presentation]. 7ème symposium du GCNAS, Louvain-la-Neuve, Belgium. |
Dmitriev, P., Stankevicins, L., Ansseau, E., Petrov, A., Barat, A., Dessen, P., Robert, T., Turki, A., Lazar, V., Labourer, E., Belayew, A., Carnac, G., Laoudj-Chenivesse, D., Lipinski, M., & Vassetzky, Y. (06 December 2013). Defective Regulation of MicroRNA Target Genes in Myoblasts from Facioscapulohumeral Dystrophy Patients. Journal of Biological Chemistry, 288, 34989-35002. Peer Reviewed verified by ORBi |
De La Kethulle De Ryhove, L., Ansseau, E., Geens, M., Coppée, F., Sermon, K., Lagneaux, L., & Belayew, A. (05 December 2013). DUX4 expression during Osteogenic Differentiation in MSCs [Poster presentation]. Journée des jeunes chercheurs Télévie, Université Catholique de Louvain, Belgium. |
 | Lancelot, C., Carnac, G., Nonclercq, D., Delrée, P., Laoudj-Chenivesse, D., Belayew, A., & Coppée, F. (28 November 2013). Development of fibrosis and its impact on muscle regeneration in FSHD muscle [Poster presentation]. 11ème Journées de la Société Française de Myologie, Montpellier, France. |
| Vanderplanck, C., Tassin, A., Lancelot, C., Ansseau, E., Nonclercq, D., Delrée, P., Laoudj-Chenivesse, D., Belayew, A., & Coppée, F. (27 November 2013). DUX4c, a DUX4-homologue, causes the FSHD disorganized myotube phenotype: an additional target for therapeutic strategies [Paper presentation]. Colloque Myogenèse XVI, Montpellier, France. |
Ansseau, E., Charron, S., Laoudj-Chenivesse, D., Coppée, F., & Belayew, A. (21 October 2013). Interplay between Sp1, YY1 and MYOD in transcription regulation of the DUX4 gene that causes facioscapulohumeral muscular dystrophy (FSHD) [Paper presentation]. FSH Society (FacioScapuloHumeral Muscular Dystrophy) International Reasearch Consortium & Reasearch Planning Meeting, Boston, United States - Massachusetts. |
Nachtergael, A., Charles, C., Spanoghe, M., Belayew, A., & Duez, P. (17 October 2013). Measurement of translesion synthesis by fluorescence capillary electrophoresis and pyrosequencing.: 8-oxodG bypass modulation by natural products [Paper presentation]. 17th Forum of Pharmaceutical Sciences, Spa, Belgium. |
Nachtergael, A., Charles, C., Spanoghe, M., Belayew, A., & Duez, P. (30 August 2013). Measurement of translesion synthesis by fluorescence capillary electrophoresis and pyrosequencing.: 8-oxodG bypass modulation by natural products [Poster presentation]. 2ndAnnual meeting of the GP-TCM Research Association, Graz, Austria. |
Nachtergael, A., Charles, C., Spanoghe, M., Belayew, A., & Duez, P. (28 August 2013). Measurement of translesion synthesis by fluorescence capillary electrophoresis and pyrosequencing.: 8-oxodG bypass modulation by natural products [Paper presentation]. 12th CGCM meeting, Graz, Austria. |
Hambye, S., Ansseau, E., Carminati, A., Vanden Eynde, J.-J., Belayew, A., & Blankert, B. (30 June 2013). Strategies for the development of a screening test in myotonic dystrophy type 1. Application to a new library of synthetized pentamidine analogs [Poster presentation]. 24th International Symposium on Pharmaceutical and Biomedical Analysis, Bologne, Italy. |
De La Kethulle De Ryhove, L., Ansseau, E., Coppée, F., & Belayew, A. (06 June 2013). DUX4 expression in embryonic stem cells [Poster presentation]. 3rd Heidelberg forum for young life scientists, DFKZ, Heidelberg, Germany. |
Hambye, S., Neaga, I.-O., Carminati, A., Ansseau, E., Vanden Eynde, J.-J., Bodoki, E., Sandulescu, R., Belayew, A., & Blankert, B. (01 June 2013). Study of nucleic acids-ligands interactions by two different strategies. Application to Myotonic Dystrophy type 1 [Poster presentation]. Health Institute Day, Mons, Umons, Belgium. |
| Ansseau, E., Vanderplanck, C., Wallace, L. M., Tassin, A., Domire, J. S., Guckes, S. M., Yip, C., Laoudj-Chenivesse, D., Coppée, F., Wilton D., S., Harper, S. Q., & Belayew, A. (24 May 2013). Evaluation of new antisense oligomers targeting the DUX4 mRNA [Poster presentation]. Journée de l'Institut de recherche en sciences et technologies de la santé, Mons, Belgium. |
 | Tassin, A., Vanderplanck, C., Ansseau, E., Derenne, A., Coppée, F., & Belayew, A. (24 May 2013). Different approaches to evaluate antisense strategies against the causal gene of the FSHD myopathy [Poster presentation]. Journée de l'Institut de recherche en sciences et technologies de la santé, Mons, Belgium. |
De La Kethulle De Ryhove, L., Geens, M., dimitrova, J., Ansseau, E., Sermon, K., & Belayew, A. (24 May 2013). DUX4 expression in embryonic stem cells [Poster presentation]. Journée de l'institut santé, Mons, Belgium. |
 | Wauters, A., Tassin, A., Leroy, B., Laval, S., Wattiez, R., Coppée, F., & Belayew, A. (24 May 2013). Caveolar proteins: putative FSHD biomarkers? [Poster presentation]. 1st Health Institute Day, Mons, Belgium. |
Lancelot, C., Carnac, G., Nonclercq, D., Delrée, P., Coppée, F., & Belayew, A. (23 May 2013). Development of fibrosis and its impact on muscle regeneration in FSHD muscle [Poster presentation]. Journée de l'institut santé, Mons, Belgium. |
Nachtergael, A., Charles, C., Spanoghe, M., Belayew, A., & Duez, P. (22 May 2013). Measurement of translesion synthesis by fluorescence capillary electrophoresis. Application to the study of 8-oxodG bypass modulation by natural products [Poster presentation]. 10e Colloque des 3R, Presqu'île de Giens, France. |
 | Sharma, V., Harafuji, N., Belayew, A., & Chen, Y.-W. (22 May 2013). DUX4 Differentially Regulates Transcriptomes of Human Rhabdomyosarcoma and Mouse C2C12 Cells. PLoS ONE, 8 (5). Peer reviewed |
Ansseau, E., Vanderplanck, C., Wallace, L. M., Tassin, A., Domire, J. S., Guckes, S. M., Yip, C., Laoudj-Chenivesse, D., Coppée, F., Wilton D., S., Harper, S. Q., & Belayew, A. (22 April 2013). Evaluation of new antisense oligomers targeting the DUX4 mRNA as a therapeutic strategy for FSHD [Paper presentation]. MDA Scientific Conference, Washington DC, United States - District of Columbia. |
Nachtergael, A., Charles, C., Spanoghe, M., Belayew, A., & Duez, P. (12 March 2013). Modulation of translesion synthesis through 8-oxo-dG by phytochemicals [Poster presentation]. 7ième Matinée des Chercheurs, Mons, Belgium. |
De La Kethulle De Ryhove, L., Ansseau, E., Coppée, F., & Belayew, A. (12 March 2013). Study of DUX4 expression and function in non-muscular cells [Poster presentation]. 7ème édition de la Matinée de Chercheurs, Mons, Belgium. |
Hambye, S., Ansseau, E., Helvenstein, M., Carminati, A., Vanden Eynde, J.-J., Belayew, A., & Blankert, B. (12 March 2013). Analytical developments and biological evaluation (in Steinert desease) of Pentamidine and new analogs [Poster presentation]. 7ième Matinée des Chercheurs, Mons, Belgium. |
Dhont, L., Denis, O., Ansseau, E., & Belayew, A. (29 January 2013). Study of the Helicase-like Transcription Factor protein partners [Poster presentation]. Journée Scientifique des Doctorants en Sciences biomédicales et pharmaceutiques; New tools and strategies in the identification of pathology-related biomarkers, Mons, Belgium. |
Hambye, S., Ansseau, E., Vanden Eynde, J.-J., Belayew, A., & Blankert, B. (29 January 2013). Strategies for the development of a new screening test in myotonic dystrophy (type I). Application to a new library of synthetized pentamidine analogs [Poster presentation]. Journée Scientifique des Doctorants en Sciences Biomédicales et Pharmaceutiques - NEW TOOLS AND STRATEGIES IN THE IDENTIFICATION OF PATHOLOGY-RELATED BIOMARKERS, Mons, Belgium. |
 | Wauters, A., Tassin, A., Leroy, B., Laval, S., Wattiez, R., Coppée, F., & Belayew, A. (29 January 2013). Caveolar proteins: putative FSHD biomarkers? [Poster presentation]. ', Journée de l'école doctorale en sciences biomédicales et pharmaceutiques, UMONS, Mons, Belgium. |
Nachtergael, A., Charles, C., Spanoghe, M., Gadenne, M., Belayew, A., & Duez, P. (01 January 2013). Measurement of translesion synthesis by fluorescent capillary electrophoresis: 8-oxodG bypass modulation by natural products. Analytical Biochemistry, 440 (1), 23-31. doi:10.1016/j.ab.2013.05.010 Peer Reviewed verified by ORBi |
 | Tassin, A., Laoudj-Chenivesse, D., Vanderplanck, C., Barro, M., Charron, S., Ansseau, E., Chen, Y.-W., Mercier, J., Coppée, F., & Belayew, A. (01 January 2013). DUX4 expression in FSHD muscle cells: how could such a rare protein cause a myopathy? Journal of Cellular Molecular Medecine, 17 (1), 1-15. doi:10.1111/j.1582-4934.2012.01647.x Peer reviewed |
Nachtergael, A., Charles, C., Spanoghe, M., Gadenne, M., Belayew, A., & Duez, P. (01 January 2013). Measurement of translesion synthesis by fluorescent capillary electrophoresis: 8-oxodG bypass modulation by natural products. Analytical Biochemistry, 440 (1), 23-31. Peer Reviewed verified by ORBi |
 | Tassin, A., Leroy, B., Laoudj-Chenivesse, D., Wauters, A., Vanderplanck, C., Le Bihan, M.-C., Coppée, F., Wattiez, R., & Belayew, A. (18 December 2012). FSHD Myotubes with Different Phenotypes Exhibit Distinct Proteomes. PLoS ONE, 7 (12), 51865. doi:10.1371/journal.pone.0051865 Peer reviewed |
De La Kethulle De Ryhove, L., Dimitrova, J., Ansseau, E., Geens, M., Lagneaux, L., Sermon, K., Coppée, F., & Belayew, A. (10 December 2012). DUX4 expression in non-muscle cells [Poster presentation]. Télévie 2013, Liège, Belgium. |
Dhont, L., Olivia, D., Ansseau, E., & Belayew, A. (10 December 2012). Study of the Helicase-like Transcription Factor protein partners [Poster presentation]. Télévie 2013, Liège, Belgium. |
 | Tassin, A., Vanderplanck, C., Leroy, B., Charron, S., Ansseau, E., Wauters, A., Laoudj-Chenivesse, D., Wattiez, R., Belayew, A., & Coppée, F. (07 November 2012). Investigations on the FSHD disorganized myotube phenotype [Poster presentation]. FSH Society International Reasearch Consortium Meeting, San Francisco, United States. |
Ansseau, E., Vanderplanck, C., Wallace, L. M., Tassin, A., Domire, J. S., Guckes, S. M., Yip, C., Laoudj-Chenivesse, D., Coppée, F., Wilton D., S., Harper, S. Q., & Belayew, A. (06 November 2012). Evaluation of new antisense oligomers targeting the DUX4 mRNA as a therapeutic strategy for FSHD [Paper presentation]. FSH Society International Reasearch Consortium Meeting, San Francisco, United States. |
Hambye, S., Ansseau, E., Vanden Eynde, J.-J., Belayew, A., & Blankert, B. (16 October 2012). Strategies for the development of a new screening test in myotonic dystrophy (type I). Application to a new library of synthetized pentamidine analogs [Poster presentation]. Journées des doctorants de l'Unité Doctorale en Sciences Pharmaceutiques ULB/UMons, Bruxelles, Belgium. |
Charron, S., Vanderplanck, C., Vancutsem, K., Laoudj-Chenivesse, D., Belayew, A., & Coppée, F. (25 September 2012). Facioscapulohumeral dystrophy: focus on the WNT perturbation [Poster presentation]. EMBO Meeting, Nice, France. |
 | Turki, A., Hayot, M., Carnac, G., Pillard, F., Passerieux, E., Bommart, S., Raynaud de Mauverger, E., Hugon, G., Pincemail, J., Pietri, S., Lambert, K., Belayew, A., Vassetzky, Y., Juntas Morales, R., Mercier, J., & Laoudj-Chenivesse, D. (11 July 2012). Functional muscle impairment in Facioscapulohumeral Muscular Dystrophy is correlated with oxidative stress and mitochondrial dysfunction. Free Radical Biology and Medicine, 53, 1068-1079. |
Charles, C., Belayew, A., & Duez, P. (11 May 2012). Influence of food plant extracts on non-homologous end-joining DNA double-strand breaks repair by on-chips microelectrophoresis [Poster presentation]. 10ème Réunion du Groupe de Contact FNRS - Phénomènes oxydatifs et antioxydants, 'Oxidative stress and genotoxic response', Mons, Belgium. |
Charron, S., Dhont, L., & Belayew, A. (2012). « De la cellule à l'ADN ». |
 | Charles, C., Ouedraogo, M., Belayew, A., & Duez, P. (23 April 2012). On-chips microelectrophoresis for the study of in vitro non-homologous end-joining DNA double-strand break repair. Analytical Biochemistry, 425 (1), 76-79. Peer Reviewed verified by ORBi |
Charron, S., Belayew, A., & Coppée, F. (29 November 2011). WNT et FOXO dans la FSHD [Paper presentation]. Merci Téléthon, Forchie-la-marche, Belgium. |
 | Richards, M., Coppée, F., Thomas, N., Belayew, A., & Upadhyaya, M. (2011). Facioscapulohumeral muscular dystrophy (FSHD): an enigma unravelled? Human Genetics. doi:10.1007/s00439-011-1100-z |
| Ansseau, E., Mattéotti, C., Gerbaux, C., Yip, C., Pire, E., Vachaudez, V., Cloet, S., Wattiez, R., Coppée, F., & Belayew, A. (07 November 2011). DUX4 and DUX4c protein partners in muscle cells [Poster presentation]. FSH Society (FSHD) 2011 International Research Consortium and Researchplanning meetings, Boston, United States - Massachusetts. |
| Charron, S., Vanderplanck, C., Laoudj-Chenivesse, D., Belayew, A., & Coppée, F. (07 November 2011). Perturbation of the WNT signaling pathway in FSHD [Paper presentation]. FSH Society (FSHD) 2011 International Research Consortium and Researchplanning meetings, Boston, United States - Massachusetts. |
| Tassin, A., Laoudj-Chenivesse, D., Charron, S., Ansseau, E., Chen, Y.-W., Mercier, J., Coppée, F., & Belayew, A. (07 November 2011). Detection of endogenous DUX4 protein in FSHD muscles: could the spreading of a rare protein cause FSHD? [Poster presentation]. FSH Society International Research Consortium & Reasearch Planning Meeting, Boston, United States - Massachusetts. |
 | Vanderplanck, C., Ansseau, E., Charron, S., Stricwant, N., Tassin, A., Laoudj-Chenivesse, D., Wilton D., S., Coppée, F., & Belayew, A. (01 November 2011). The FSHD atrophic myotube phenotype is caused by DUX4 expression and corrected by its suppression. PLoS ONE, 6 (10), 26820. doi:10.1371/journal.pone.0026820 Peer reviewed |
Charron, S., Belayew, A., & Coppée, F. (29 October 2011). La signalisation cellulaire WNT et FOXO [Paper presentation]. Assemblée générale de l'association Amis FSH Europe, Agde, France. |
 | Dmitriev, P., Petrov, A., Ansseau, E., Stankevicins, L., Charron, S., Kim, E., Bos, T., Robert, T., Turki, A., Coppée, F., Belayew, A., Lazar, V., Carnac, G., Laoudj-Chenivesse, D., Lipinski, M., & Vassetzky, Y. (21 September 2011). The Kruppel-like Factor 15 as a Molecular Link between Myogenic Factors and a Chromosome 4q Transcriptional Enhancer Implicated in Facioscapulohumeral Dystrophy. Journal of Biological Chemistry, 286, 44620-44631. Peer Reviewed verified by ORBi |
| Tassin, A., Leroy, B., Ansseau, E., Pire, E., Faille, J., Leclercq, T., Charron, S., Vanderplanck, C., Wauters, A., Turky, D., Laoudj-Chenivesse, D., Coppée, F., Wattiez, R., & Belayew, A. (12 May 2011). The galectin-1 gene is activated in FSHD Myotubes as a result of the DUX4 transcriptional deregulation cascade [Poster presentation]. 4th international congress of myology 2011, Lille , France. |
Vanderplanck, C., Coppée, F., Ansseau, E., Tassin, A., Charron, S., Laoudj-Chenivesse, D., Wilton D., S., & Belayew, A. (12 May 2011). Interfering with the transcription deregulation cascades in fshd [Paper presentation]. 4th international congress of myology 2011, Lille , France. |
 | Ansseau, E., Charron, S., Guiguen, A., Van Lint, C., Coppée, F., & Belayew, A. (12 May 2011). YY1 and MyoD are transcriptional activator and inhibitor, respectively, of the DUX4 gene that causes facioscapulohumeral muscular dystrophy (FSHD) [Poster presentation]. 4th international congress of myology 2011, Lille , France. |
Vanderplanck, C., Ansseau, E., Charron, S., Tassin, A., Turki, A., Laoudj-Chenivesse, D., Wilton D., S., Coppée, F., & Belayew, A. (06 May 2011). SUPPRESSION OF DUX4 OR DUX4C EXPRESSION BY ANTISENSE STRATEGIES IN A THERAPEUTIC APPROACH FOR FSHD [Paper presentation]. 7th AGTS Meeting, Melbourne, Australia. |
Charles, C., Belayew, A., & Duez, P. (02 May 2011). Etude en microélectrophorèse capillaire de l'influence de produits naturels sur la réparation in vitro des cassures double-brin de l'ADN par recombinaison non-homologue [Poster presentation]. 9ème Colloque des 3R : Réplication, Recombinaison et Réparation, Presqu'île de Giens, France. |
 | Capouillez, A., Noel, J., Arafa, M., Arcolia, V., Mouallif, M., Guenin, S., Delvenne, P., Belayew, A., & Saussez, S. (01 May 2011). Expression of the helicase-like transcription factor and its variants during carcinogenesis of the uterine cervix: implications for tumour progression. Histopathology, 58 (6), 984-988. Peer Reviewed verified by ORBi |
Ansseau, E., Charron, S., Guiguen, A., Van Lint, C., Coppée, F., & Belayew, A. (22 March 2011). YY1 and MyoD are transcriptional activator and inhibitor, respectively, of the DUX4 gene that causes facioscapulohumeral muscular dystrophy (FSHD) [Poster presentation]. La matinée des chercheurs, Mons, Unknown/unspecified. |
 | Raquez, J. M., Barone, D., Luklinska, Z., Persenaire, O., Belayew, A., Eyckmans, J., Schrooten, J., & Dubois, P. (14 March 2011). Osteoconductive and Bioresorbable Composites Based on Poly(l,l-lactide) and Pseudowollastonite: From Synthesis and Interfacial Compatibilization to In Vitro Bioactivity and In Vivo Osseointegration Studies. Biomacromolecules, 12, 692-700. Peer Reviewed verified by ORBi |
Vanderplanck, C., Coppée, F., Ansseau, E., Tassin, A., Charron, S., Laoudj-Chenivesse, D., Wilton D., S., & Belayew, A. (14 March 2011). Suppression of DUX4 or DUX4c protein expression by antisense strategies in a therapeutic approach for FSHD [Paper presentation]. MDA national scientific conference Neuromuscular Therapeutic Strategies: Overcoming the Barriers from Microscope to Marketplace, Las Vegas, United States - Nevada. |
Charron, S., & Belayew, A. (2011). Visite Guidée du Laboratoire de Biologie Moléculaire. |
Belayew, A. (2011). A long road in FSHD research. |
Charles, C., Moreno Y Banuls, L., Belayew, A., & Duez, P. (22 December 2010). Influence of natural compounds on non-homologous end-joining DNA double-strand breaks repair by on-chips microelectrophoresis [Paper presentation]. 9ème Réunion du Groupe de Contact FNRS - Phénomènes oxydatifs et antioxydants, Bruxelles, Belgium. |
Belayew, A. (25 November 2010). Perturbations de réseaux de gènes dans la FSHD [Paper presentation]. VIIIè journées annuelles Société Française de Myologie, Nice, France. |
Tassin, A., Leroy, B., Ansseau, E., Pire, E., Faille, J., Leclercq, T., Charron, S., Laoudj-Chenivesse, D., Coppée, F., Wattiez, R., & Belayew, A. (25 November 2010). Focus on nuclear proteins of FSHD primary myotubes by differential mass spectrometry [Poster presentation]. VIIIè journées annuelles Société Française de Myologie, Nice, France. |
Belayew, A. (20 November 2010). Global gene deregulation in facioscapulohumeral muscular dystrophy [Paper presentation]. 10th Anniversary Symposium Centre de Référence Neuromusculaire (CRNM): Progress in neuromuscular disorders, UCL Saint-Luc, Bruxelles, Belgium. |
Wallace, L. M., Garwick, S. E., Mei, W., Belayew, A., Coppée, F., Ladner, K., Guttridge, D., Yang, J., & Harper, S. Q. (02 November 2010). DUX4 over-expression recapitulates FSHD-associated phenotypes in vivo [Paper presentation]. American Society of Human Genetics, 2010 Annual Meeting, Washington DC, United States - District of Columbia. |
Belayew, A. (30 October 2010). Suppression de l'expression de DUX4 ou DUX4c comme approche thérapeutique pour la FSHD [Paper presentation]. ASSEMBLEE GENERALE DE L'ASSOCIATION AMIS FSH EUROPE, Agde, France. |
 | Wallace, L. M., Garwick, S. E., Mei, W., Belayew, A., Coppée, F., Ladner, K. J., Guttridge, D., Yang, J., & Harper, S. Q. (2010). DUX4, a candidate gene for facioscapulohumeral muscular dystrophy, causes p53-dependent myopathy in vivo. Annals of Neurology. doi:10.1002/ana.22275 Peer Reviewed verified by ORBi |
Charles, C., Moreno Y Banuls, L., Stevigny, C., Belayew, A., & Duez, P. (26 October 2010). Effect of ten flavonoids, curcumin and indole-3-carbinol on in vitro DNA double-strand breaks repair [Paper presentation]. 5ème symposium du Groupe de Contact FNRS - Nutrition, Alimentation et Santé (GCNAS), Bruxelles, Belgium. |
Tassin, A., Leroy, B., Ansseau, E., Pire, E., Charron, S., Coppée, F., Wattiez, R., & Belayew, A. (25 October 2010). Focus on nuclear proteins of FSHD primary myotubes by differential mass spectrometry [Poster presentation]. FSHD International Research Consortium Meeting, Boston, United States - Massachusetts. |
Vanderplanck, C., Coppée, F., Ansseau, E., Tassin, A., Laoudj-Chenivesse, D., Wilton D., S., & Belayew, A. (21 October 2010). Suppression of DUX4 or DUX4c protein expression by antisense strategies as a therapeutic approach for FSHD [Paper presentation]. FSH Society International Research Consortium & Research Planning Meeting, Boston, United States - Massachusetts. |
Belayew, A. (2010). A long walk towards a key role of DUX4 in FSHD. |
Charles, C., Moreno Y Banuls, L., Belayew, A., Stevigny, C., & Duez, P. (21 September 2010). Development of on-chips microelectrophoresis for the study of ex-vivo non-homologous end-joining DNA double-strand breaks repair. Effect of quercetin [Poster presentation]. Drug Analysis, Antwerpen, Belgium. |
Vanderplanck, C., Ansseau, E., Coppée, F., Belayew, A., & Wilton D., S. (01 September 2010). Agents useful in treating Facioscapulohumeral muscular dystrophy. |
Belayew, A. (30 January 2010). Une activation de gènes en cascade dans la dystrophie musculaire facioscapulohumérale. Bulletin et Mémoires de l'Académie Royale de Médecine de Belgique, 165 (1-2), 87-97. |
Tassin, A., Coppée, F., Leroy, B., Sauvage, S., Preillon, J., Erculisse, V., Charron, S., Vanderplanck, C., Barro, M., Vander Elst, L., Muller, R., Laoudj-Chenivesse, D., Colet, J.-M., Wattiez, R., & Belayew, A. (09 November 2009). Investigations on the molecular mechanism of a muscular dystrophy (FSHD) by proteomic and metabonomic analyses of primary myoblast cultures [Paper presentation]. FSH Society International Research Consortium and Research Planning Meetings, Boston, United States - Massachusetts. Editorial reviewed |
Dmitriev, P., Petrov, A., Ansseau, E., Charron, S., Coppée, F., Belayew, A., Carnac, G., Turki, A., Laoudj-Chenivesse, D., Lipinski, M., & Vassetzky, Y. (06 November 2009). Kruppel-like factor KLF15 interacts with the D4Z4 enhancer and upregulates a FSHD-related gene DUX4c [Poster presentation]. FSH Society International Research Consortium and Research Planning Meetings, Boston, United States - Massachusetts. |
 | Tassin, A., Charron, S., Vanderplanck, C., Coppée, F., & Belayew, A. (2009). Des techniques en 'omique' pour comprendre une maladie héréditaire des muscles. |
Tassin, A., & Belayew, A. (31 October 2009). Etude des protéines DUX4, DUX4c, PITX1 et de leur rôle dans le mécanisme moléculaire de la FSHD [Paper presentation]. Assemblée Générale des Amis FSH Europe, Agde, France. |
Charron, S., Vanderplanck, C., Belayew, A., & Coppée, F. (17 October 2009). WNT and FOXO signaling pathways in FSHD [Poster presentation]. Protein modifications in development and diseases, Liège, Belgium. |
 | Ansseau, E., Laoudj-Chenivesse, D., Marcowycz, A., Tassin, A., Vanderplanck, C., Sauvage, S., Barro, M., Mahieu, I., Leroy, A., Leclercq, I., Mainfroid, V., Figlewicz, D., Mouly, V., Butler-Browne, G., Belayew, A., & Coppée, F. (01 October 2009). DUX4c Is Up-Regulated in FSHD. It Induces the MYF5 Protein and Human Myoblast Proliferation. PLoS ONE, 4 (10), 7482. doi:10.1371/journal.pone.0007482 Peer reviewed |
 | Capouillez, A., Debauve, G., Decaestecker, C., Filleul, O., Chevalier, D., Mortuaire, G., Coppée, F., Leroy, X., Belayew, A., & Saussez, S. (01 September 2009). The Helicase-Like Transcription Factor is a strong predictor of recurrence in Hypopharyngeal but not in Laryngeal squamous cell carcinomas. Histopathology, 55, 77-90. Peer Reviewed verified by ORBi |
Tassin, A., Coppée, F., Leroy, B., Erculisse, V., Sauvage, S., Charron, S., Vanderplanck, C., Barro, M., Vander Elst, L., Muller, R., Laoudj-Chenivesse, D., Colet, J.-M., Wattiez, R., & Belayew, A. (27 July 2009). Investigations on the molecular mechanism of a muscular dystrophy (FSHD) by proteomic and metabonomic analyses of primary myoblast cultures [Paper presentation]. International Symposium Signal transduction and disease, Aachen, Germany. Editorial reviewed |
 | Dumonceaux, J., Marie, S., Ferry, A., Coppée, F., Belayew, A., Voit, T., & Butler-Browne, G. (2009). Dux4 over-expression in normal mouse: Generation of a mouse model with an FSHD phenotype? [Paper presentation]. 14th International WMS Congress, Genève, Switzerland. |
 | Aouay, A., Coppée, F., Cloet, S., Cuvelier, P., Belayew, A., Lagneau, P.-E., & Mullender, C. (01 November 2008). Molecular characterization of Prototheca strains isolated from bovine mastitis. Journal de Mycologie Médicale, 18, 224-227. doi:10.1016/j.mycmed.2008.10.002 Peer reviewed |
 | Bosnakovski, D., Lamb, S., Simsek, T., Xu, Z., Belayew, A., Perlingeiro, R., & Kyba, M. (01 November 2008). DUX4c, an FSHD candidate gene, interferes with myogenic regulators and abolishes myoblast differentiation. Experimental Neurology, 214 (1), 87-96. doi:10.1016/j.expneurol.2008.07.022 Peer Reviewed verified by ORBi |
 | Bosnakovski, D., Xu, Z., Gang, E. J., Galindo, C. L., Liu, M., Simsek, T., Garner, H. R., Agha-Mohammadi, S., Tassin, A., Coppée, F., Belayew, A., Perlingeiro, R., & Kyba, M. (01 October 2008). An isogenetic myoblast expression screen identifies DUX4-mediated FSHD-associated molecular pathologies. EMBO Journal, 27 (20), 2766-79. Peer Reviewed verified by ORBi |
Tassin, A., Vanderplanck, C., Ansseau, E., Marcowyzc, A., Barro, M., Laoudj-Chenivesse, D., Belayew, A., & Coppée, F. (26 May 2008). Studies on the expression and function of DUX4c, a gene located close to the FSHD locus [Poster presentation]. 3ème Congrès International de Myologie, Marseille, France. |
Belayew, A. (2008). Un gène toxique dans les poubelles ! |
Tassin, A., Ansseau, E., Vanderplanck, C., Cloet, S., Barro, M., Laoudj-Chenivesse, D., Chen, Y.-W., Belayew, A., & Coppée, F. (21 January 2008). DUX4 and DUX4c activate different pathways in Facioscapulohumeral dystrophy [Paper presentation]. Colloque « Myogenese IX », Institut de Myologie, Paris, France. Editorial reviewed |
 | Capouillez, A., Decaestecker, C., Filleul, O., Chevalier, D., Coppée, F., Leroy, X., Belayew, A., & Saussez, S. (01 January 2008). Helicase-like transcription factor exhibits increased expression and altered intracellular distribution during tumor progression in hypopharyngeal and laryngeal squamous cell carcinomas. Virchows Archiv, 453 (5), 491-499. Peer Reviewed verified by ORBi |
 | Debauve, G., Capouillez, A., Belayew, A., & Saussez, S. (01 January 2008). HLTF and its implication in cancer progression. Cellular and Molecular Life Sciences, 65 (4), 591-604. doi:10.1007/s00018-007-7392-4 Peer Reviewed verified by ORBi |
 | Tassin, A., Vanderplanck, C., Ansseau, E., Cloet, S., Barro, M., Laoudj-Chenivesse, D., Dabauvalle, M. C., Wehnert, M., Chen, Y.-W., Belayew, A., & Coppée, F. (2008). Study of DUX4 and DUX4c in facioscapulohumeral muscular dystrophy [Paper presentation]. 13th International WMS Congress, Newcastle upon Tyne, United Kingdom. |
 | Belayew, A. (2008). A contribution of ''junk DNA' and transcription factors to the molecular
mechanism of FSHD [Paper presentation]. 13th International WMS Congress, Newcastle upon Tyne, United Kingdom. |
 | Belayew, A. (2008). Homeodomain transcription factors DUX4, PITX1 and DUX4c: new actors in the molecular mechanism of FSHD [Paper presentation]. 3rd International Congress of Myology, Marseille, France. |
Ansseau, E., Tassin, A., Vanderplanck, C., Cloet, S., Barro, M., Laoudj-Chenivesse, D., Chen, Y.-W., Belayew, A., & Coppée, F. (04 November 2007). Further studies on the DUX4, DUX4c and PITX1 genes in FSHD [Paper presentation]. FSHD international Workshop meeting, San Diego, United States - California. |
 | Dixit, M., Ansseau, E., Tassin, A., Winokur, S., Shi, R., Qian, H., Sauvage, S., Mattéotti, C., van Acker, A., Leo, O., Figlewicz, D., Barro, M., Laoudj-Chenivesse, D., Belayew, A., Coppée, F., & Chen, Y.-W. (01 November 2007). DUX4, a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1. Proceedings of the National Academy of Sciences of the United States of America, 104 (46), 18157-18162. doi:10.1073/pnas.0708659104 Peer Reviewed verified by ORBi |
 | Kowaljow, V., Marcowycz, A., Ansseau, E., Conde, C. B., Sauvage, S., Mattéotti, C., Arias, C., Corona, E. D., Nuñez, N. G., Leo, O., Wattiez, R., Figlewicz, D., Laoudj-Chenivesse, D., Belayew, A., Coppée, F., & Rosa, A. L. (01 June 2007). The DUX4 gene at the FSHD1A locus encodes a pro-apoptotic protein. Neuromuscular Disorders, 17 (8), 611-23. doi:10.1016/j.nmd.2007.04.002 Peer Reviewed verified by ORBi |
Tassin, A., Ansseau, E., Sauvage, S., Mattéotti, C., Van Acker, A.-M., Figlewicz, D., Laoudj-Chenivesse, D., Oberdan, L., Coppée, F., & Belayew, A. (18 December 2006). Evidence for the expression of the DUX4 gene in primary myoblasts of patients affected with Facioscapulohumeral muscular dystrophy [Poster presentation]. 194th Congrès de la Société Belge de Biochimie et de Biologie Moléculaire / 'Young Scientists Day, Gembloux, Belgium. |
 | Ansseau, E., Laoudj-Chenivesse, D., Marcowycz, A., Sauvage, S., Barro, M., Tassin, A., Mattéotti, C., van Acker, A., Leroy, A., Leclercq, I., Leo, O., Figlewicz, D., Belayew, A., & Coppée, F. (2006). Characterization of the DUX4c gene located within a repeated element close to the FSHD locus [Paper presentation]. 11th International Congress of the World Muscle Society, Bruges, Belgium. |
Ansseau, E., Tassin, A., Sauvage, S., Laoudj-Chenivesse, D., Barro, M., Figlewicz, D., Coppée, F., & Belayew, A. (09 October 2006). DUX4 gene expression in FSHD primary myoblasts [Paper presentation]. FSHD International Consortium Research Meeting, New Orleans, United States - Louisiana. |
Debauve, G., Nonclercq, D., Ribaucour, F., Wiedig, M., Gerbaux, C., Leo, O., Laurent, G., Journé, F., Belayew, A., & Toubeau, G. (08 June 2006). Early expression of the Helicase-Like Transcription Factor (HLTF/SMARCA3) in an experimental model of estrogen-induced renal carcinogenesis. Molecular Cancer, 5, 23-34. doi:10.1186/1476-4598-5-23 Peer reviewed |
Ansseau, E., Coppée, F., & Belayew, A. (20 May 2006). Fonctional characterization of the DUX4 et DUX4c genes located within repeated elements at the FSHD locus [Poster presentation]. Bioforum, Liège, Belgium. |
Marcowycz, A., Mahieu, I., Tassin, A., Coppée, F., & Belayew, A. (17 May 2006). The DUX4 and DUX4c proteins, encoded by candidate genes for a muscular dystrophy (FSHD), have opposite functions in vivo [Poster presentation]. Bioforum, Liège, Belgium. |
 | Ansseau, E., Laoudj-Chenivesse, D., Marcowycz, A., Barro, M., Sauvage, S., Mattéotti, C., Mahieu, I., Tassin, A., Van Acker, A.-M., Leo, O., Fliglewicz, D., Coppée, F., & Belayew, A. (13 January 2006). Etude de DUX4 et DUX4c, gènes candidats pour la FSHD [Paper presentation]. Club muscle 'V', Paris, France. |
 | Laumonier, C., Segers, J., Laurent, S., Michel, A., Coppée, F., Belayew, A., Vander Elst, L., & Muller, R. (01 January 2006). A new peptidic vector for molecular imaging of apoptosis, identified by phage display technology. Journal of Biomolecular Screening, 11 (5), 537-545. doi:10.1177/1087057106288220 Peer Reviewed verified by ORBi |
Tassin, A., Sauvage, S., Mattéotti, C., Van Acker, A.-M., Figlewicz, D., Padberg, G. W., Oberdan, L., Coppée, F., & Belayew, A. (25 October 2005). Studies on the expression of the DUX4 and DUX4c proteins [Poster presentation]. FSHD International Consortium Research Meeting, Salt Lake City, United States - Utah. |
Laoudj-Chenivesse, D., Barro, M., Sauvage, S., Tassin, A., Ansseau, E., Marcowycz, A., Figlewicz, D., Van Acker, A.-M., Leo, O., Belayew, A., & Coppée, F. (25 October 2005). Overexpression of the double homeodomain protein DUX4c in FSHD muscle [Paper presentation]. FSHD International Consortium Research Meeting, Salt Lake City, United States - Utah. |
Belayew, A., Ansseau, E., Sauvage, S., Marcowycz, A., Laoudj-Chenivesse, D., Carnac, G., Mattéotti, C., Gerbaux, C., Mahieu, I., Zorbo, S., Leclercq, I., Tassin, A., Figlewicz, D., & Coppée, F. (09 June 2005). Etude fonctionnelle de DUX4 et DUX4c, et de leur rôle dans la dystrophie de Landouzy-Dejerine [Paper presentation]. Meeting « Club Muscle IV », Marseille, France. |
Ansseau, E., Sauvage, S., Laoudj-Chenivesse, D., Carnac, G., Marcowyzc, A., Leroy, A., Leclercq, I., Figlewicz, D., Belayew, A., & Coppée, F. (27 May 2005). Characterization of DUX4c, a double homeobox gene located in a truncated and inverted D4Z4 element, and its expression in FSHD mlyoblasts [Poster presentation]. 190th meeting of the Belgian Society of Biochemistry and Molecular Biology, Mons, Belgium. |
Ansseau, E., Sauvage, S., Laoudj-Chenivesse, D., Carnac, G., Marcowycz, A., Leroy, A., Leclercq, I., Figlewicz, D., Belayew, A., & Coppée, F. (09 May 2005). Characterization of DUX4c, a double homeobox gene located in a truncated and inverted D4Z4 element, and its expression in FSHD mlyoblasts [Poster presentation]. Congrès Myologie 2005, Nantes, France. |
 | Östlund, C., Garcia-Carrasquillo, R. M., Belayew, A., & Worman, H. J. (01 February 2005). Intracellular Trafficking and Dynamics of Double Homeodomain Proteins. Biochemistry, 44, 2378-2384. Peer Reviewed verified by ORBi |
Östlund, C., Garcia-Carrasquillo, R. M., Belayew, A., & Worman, H. J. (25 January 2005). Intracellular trafficking and dynamics of double homeodomain proteins. Biochemistry, 7, 2378-2384. Peer Reviewed verified by ORBi |
Ansseau, E., Coppée, F., D'Amico, E., Marcowycz, A., Mattéotti, C., Sauvage, S., Wiilocq, J., & Belayew, A. (26 October 2004). Functional study of the DUX4 and DUX4c genes [Paper presentation]. FSHD International Consortium Research Meeting, Toronto, Canada. |
Sekkali, B., Brim, H., Argenton, F., Bortolussi, M., Colombo, L., Belayew, A., & Martial, J. (05 July 2004). Structure and functional analysis of a tilapia (Oreochromis mossambicus) growth hormone gene: activation and repression by pituitary transcription factor Pit-1. DNA and Cell Biology, 18 (6), 489-502. Peer Reviewed verified by ORBi |
Coppée, F., Mattéotti, C., Ansseau, E., Sauvage, S., Leclercq, I., Leroy, A., Marcowyzc, A., Gerbaux, C., Figlewicz, D., Ding, H., & Belayew, A. (2004). The DUX gene family and FSHD. In Facioscapulohumeral Muscular Dystrophy: Clinical Medicine and Molecular Biology (pp. 117-134). Bios. Scientific publisher. |
Ansseau, E., Coppée, F., & Belayew, A. (2003). Publication of a sequence in GeneBank 'accession num. EMBL/Genbank: AY500824 :Homo sapiens double homeobox4c (DUX4c) gene, complete cds'. |
 | Marcowyzc, A., Ansseau, E., Sauvage, S., Mattéotti, C., Zorbo, S., Belayew, A., & Coppée, F. (04 November 2003). Characterization of DUX4c and its role in facioscapulohumeral dystrophy (FSHD) [Poster presentation]. FSHD International Consortium Research Meeting, Los Angeles, United States. |
 | Ansseau, E., Coppée, F., & Belayew, A. (01 October 2003). Etude de l'élément cis répresseur du locus D4Z4 et de son rôle dans l'expression de DUX4, un gène candidat pour la dystrophie facio-scapulo-humérale (FSHD) [Poster presentation]. 1ère journées annuelles de Société Française de Myologie, Caen, France. |
 | Marcowycz, A., Ansseau, E., Coppée, F., & Belayew, A. (01 October 2003). Caractérisation du gène et de la protéine DUX4c [Paper presentation]. 1ère journées annuelles de la société française de Myologie, Caen, France. |
Ansseau, E., Sauvage, S., Mattéotti, C., Marcowyzc, A., Belayew, A., & Coppée, F. (30 September 2003). Functional study of the DUX4 gene [Poster presentation]. FSHD International Consortium Research Meeting, Los Angeles, United States. |
 | Beckers, M.-C., Gabriëls, J., van der Maarel, S., De Vriese, A., R. Frants, R., Collen, D., & Belayew, A. (07 February 2001). Active genes in junk DNA? Characterization of DUX genes embedded within 3.3 kb repeated elements. Gene, 1 (264), 51-57. Peer Reviewed verified by ORBi |
Van de Weerdt, C., Peers, B., Belayew, A., Martial, J., & Muller, M. (01 February 2000). Far upstream sequences regulate the human prolactin promoter transcription. Neuroendocrinology, 71, 124-137. Peer Reviewed verified by ORBi |
 | Merchiers, P., Bulens, F., Stockmans, I., De Vriese, A., Convents, R., Bouillon, R., Collen, D., Belayew, A., & Carmeliet, G. (29 October 1999). 1,25-Dihydroxyvitamin D(3) induction of the tissue-type plasminogen activator gene is mediated through its multihormone-responsive enhancer. FEBS Letters, 460 (2), 289-296. Peer Reviewed verified by ORBi |
 | Gabriëls, J., Beckers, M.-C., Ding, H., De Vriese, A., Plaisance, S., van der Maarel, S., Padberg, G. W., R. Frants, R., Hewitt, J. E., Collen, D., & Belayew, A. (05 August 1999). Nucleotide sequence of the partially deleted D4Z4 locus in a patient with FSHD identifies a putative gene within each 3.3 kb element. Gene, 1 (236), 25-32. Peer Reviewed verified by ORBi |
 | Merchiers, P., Bulens, F., De Vriese, A., Collen, D., & Belayew, A. (30 July 1999). Involvement of Sp1 in basal and retinoic acid induced transcription of the human tissue-type plasminogen activator gene. FEBS Letters, 456 (1), 149-154. Peer Reviewed verified by ORBi |
 | Ding, H., Benotmane, M. A., Suske, G., Collen, D., & Belayew, A. (1999). Functional interactions between Sp1 or Sp3 and the Helicase-like Transcription Factor mediate basal expression from the human PAI-1. Journal of Biological Chemistry, (274), 19573-19580. Peer Reviewed verified by ORBi |
 | Sekkali, B., Belayew, A., Bortolussi, M., Martial, J., & Muller, M. (25 June 1999). Pit-1 mediates cell-specific and cAMP-induced transcription of the tilapia GH gene. Molecular and Cellular Endocrinology, 152 (1-2), 111-123. Peer Reviewed verified by ORBi |
Sekkali, B., Brim, H., Muller, M., Argenton, F., Bortolussi, M., Colombo, L., Belayew, A., & Martial, J. (18 June 1999). Structure and functional analysis of a tilapia (Oreochromis mossambicus) growth hormone gene: activation and repression by pituitary transcription factor Pit-1. DNA and Cell Biology, 18 (6), 489-502. Peer Reviewed verified by ORBi |
 | Ding, H., Beckers, M.-C., Plaisance, S., Marynen, P., Collen, D., & Belayew, A. (1998). Characterization of a double homeodomain protein (DUX1) encoded by a cDNA homologous to 3.3 kb dispersed repeated elements. Human Molecular Genetics, (11), 1681-1694. Peer Reviewed verified by ORBi |
Odaka, K., Lijnen, H., Dewerchin, M., Belayew, A., Matsuo, O., Collen, D., & Bernaerts, R. (01 September 1997). Characterization and targeting of the murine alpha2-antiplasmin gene. Journal of Thrombosis and Haemostasis, 78 (3), 1104-1110. Peer Reviewed verified by ORBi |
 | Benotmane, M. A., Hoylaerts, M., Collen, D., & Belayew, A. (01 August 1997). Nonisotopic quantitative analysis of protein-DNA interactions at equilibrium. Analytical Biochemistry, 250 (2), 181-185. Peer Reviewed verified by ORBi |
 | Bulens, F., Merchiers, P., Ibañez-Tallon, I., De Vriese, A., Nelles, L., Claessens, F., Belayew, A., & Collen, D. (1997). Identification of a multihormone responsive enhancer far upstream from the human tissue-type plasminogen activator. Journal of Biological Chemistry, (272), 663-671. Peer Reviewed verified by ORBi |
Jacquemin, P., Alsat, E., Oury, C., Belayew, A., Muller, M., Evain-Brion, D., & Martial, J. (01 October 1996). The enhancers of the human placental lactogen B, A, and L genes: progressive activation during in vitro trophoblast differentiation and importance of the DF-3 element in determining their respective activities. DNA and Cell Biology, 15 (10), 845. doi:10.1089/dna.1996.15.845 Peer Reviewed verified by ORBi |
Poncelet, A., Levavi-Sivan, B., Muller, M., Yaron, Z., Martial, J., & Belayew, A. (01 August 1996). The tilapia prolactin I gene: evolutionary conservation of the regulatory elements directing pituitary-specific expression. DNA and Cell Biology, 15 (8), 679-692. Peer Reviewed verified by ORBi |
Ding, H., Descheemaeker, K., Marynen, P., Nelles, L., Carvalho, T., Carmo-Fonseca, M., Collen, D., & Belayew, A. (01 June 1996). Characterization of a helicase-like transcription factor involved in the expression of the human plasminogen activator inhibitor-1 gene. DNA and Cell Biology, 15 (6), 429-442. Peer Reviewed verified by ORBi |
Weras, S., Zengh, L., Hooghe-Peters, E., Belayew, A., Martial, J., & Velkeniers, B. (11 August 1995). Cyclosporin A, rapamycin and FK506 decrease prolactin release from rat pituitary cells in primary culture. Endocrine Research, 21 (3), 623-633. Peer Reviewed verified by ORBi |
 | Bulens, F., Ibañez-Tallon, I., Van Acker, P., De Vriese, A., Nelles, L., Belayew, A., & Collen, D. (1995). Retinoic acid induction of human tissue-type plasminogen activator (t-PA) gene expression via a direct repeat element (DR5) located at -7 kb. International Journal of Biological Chemistry, (270), 7167-7175. Peer Reviewed verified by ORBi |
 | Weras, S., Belayew, A., & Martial, J. (23 January 1995). Rapamycin, FK506 and cyclosporin A inhibit human prolactin gene expression. FEBS Letters, 358 (2), 158-160. Peer Reviewed verified by ORBi |
Jacquemin, P., Oury, C., Belayew, A., & Martial, J. (01 October 1994). A TEF-1 binding motif that interacts with a placental protein is important for the transcriptional activity of the hCS-B enhancer. DNA and Cell Biology, 13 (10), 1037-1045. Peer Reviewed verified by ORBi |
Volckaert, F., Hellemans, B., Galbusera, P., Ollevier, F., Sekkali, B., & Belayew, A. (01 April 1994). Replication, expression, and fate of foreign DNA during embryonic and larval development of the African catfish (Clarias gariepinus). Molecular Marine Biology and Biotechnology, 3 (2), 57-69. Peer Reviewed verified by ORBi |
 | Jacquemin, P., Oury, C., Peers, B., Morin, A., Belayew, A., & Martial, J. (01 January 1994). Characterization of a single strong tissue-specific enhancer downstream from the three human genes encoding placental lactogen. Molecular and Cellular Biology, 14 (1), 93-103. Peer Reviewed verified by ORBi |
Jacquemin, P., Alsat, E., Oury, C., Belayew, A., Martial, J., & Evain-Brion, D. (15 October 1993). ficient lipofection of human trophoblast cells in primary cultures. Biochemical and Biophysical Research Communications, 196 (1), 376-381. Peer Reviewed verified by ORBi |
Weras, S., Belayew, A., & Martial, J. (01 July 1993). Okadaic acid, a protein phosphatase inhibitor, enhances transcription of a receptor gene containing sequence A of the human prolactin promoter. Molecular Endocrinology, 7 (8), 965-971. Peer Reviewed verified by ORBi |
 | Pernasetti, F., Weras, S., Belayew, A., & Martial, J. (11 June 1993). Cloning of a human GHF-1/Pit-1 cDNA variant. Nucleic Acids Research, 21 (15). Peer Reviewed verified by ORBi |
Argenton, F., Vianello, S., Bernardini, S., Jacquemin, P., Martial, J., Belayew, A., Colombo, L., & Bortolussi, M. (14 May 1993). The transcriptional regulation of the growth hormone gene is conserved in vertebrate evolution. Biochemical and Biophysical Research Communications, 192 (3), 1360-1366. Peer Reviewed verified by ORBi |
Berwaer, M., Peers, B., Nalda, A.-M., Monget, P., Davis, J., Belayew, A., & Martial, J. (01 March 1993). Thyrotropin-releasing hormone and epidermal growth factor induce human prolactin expression via identical multiple cis elements. Molecular and Cellular Endocrinology, 92 (1), 1-7. Peer Reviewed verified by ORBi |
 | Peers, B., Nalda, A.-M., Monget, P., Voz, M., Belayew, A., & Martial, J. (01 November 1992). Binding of a 100-kDa ubiquitous factor to the human prolactin promoter is required for its basal and hormone-regulated activity. European Journal of Biochemistry, 210 (1), 53-58. Peer Reviewed verified by ORBi |
Swennen, D., Poncelet, A., Sekkali, B., Rentier-Delrue, F., Martial, J., & Belayew, A. (1992). Structure of the tilapia (Oreochromis mossambicus) prolactin I gene. DNA and Cell Biology. Peer Reviewed verified by ORBi |
 | Voz, M., Peers, B., Wiedig, M., Jacquemin, P., Belayew, A., & Martial, J. (01 September 1992). Transcriptional regulation by triiodothyronine requires synergistic action of the thyroid receptor with another trans-acting factor. Molecular and Cellular Biology, 12 (9), 3991-3997. Peer Reviewed verified by ORBi |
Hoggard, N., Davis, J., Berwaer, M., Monget, P., Peers, B., Belayew, A., & Martial, J. (01 November 1991). Pit-1 binding sequences permit calcium regulation of human prolactin gene expression. Molecular Endocrinology, 5 (11), 1748-1754. Peer Reviewed verified by ORBi |
 | Peers, B., Monget, P., Nalda, A.-M., Voz, M., Berwaer, M., Belayew, A., & Martial, J. (25 September 1991). Transcriptional induction of the human prolactin gene by cAMP requires two cis-acting elements and at least the pituitary-specific factor Pit-1. Journal of Biological Chemistry, 266 (27), 18127-18134. Peer Reviewed verified by ORBi |
Berwaer, M., Monget, P., Peers, B., Mathy-Hartert, M., Bellefroid, E., Davis, J., Belayew, A., & Martial, J. (01 September 1991). Multihormonal regulation of the human prolactin gene expression from 5000 bp of its upstream sequence. Molecular and Cellular Endocrinology, 80 (1-3), 53-64. Peer Reviewed verified by ORBi |
 | Voz, M., Peers, B., Belayew, A., & Martial, J. (15 July 1991). Characterization of an unusual thyroid response unit in the promoter of the human placental lactogen gene. Journal of Biological Chemistry, 266 (20), 13397-13404. Peer Reviewed verified by ORBi |
 | Peers, B., Voz, M., Monget, P., Mathy-Hartert, M., Berwaer, M., Belayew, A., & Martial, J. (01 September 1990). Regulatory elements controlling pituitary-specific expression of the human prolactin gene. Molecular and Cellular Biology, 10 (9), 4690-4700. Peer Reviewed verified by ORBi |
Morin, A., Louette, J., Voz, M., Tixier-Vidal, A., Belayew, A., & Martial, J. (09 July 1990). Triiodothyronine inhibits transcription from the human growth hormone promoter. Molecular and Cellular Endocrinology, 71 (3), 261-267. Peer Reviewed verified by ORBi |
Bellefroid, E., Lecocq, P., Benhida, A., Poncelet, D., Belayew, A., & Martial, J. (30 July 1989). The human genome contains hundreds of genes coding for finger proteins of the Krüppel type. DNA, 8 (6), 377-387. Peer Reviewed verified by ORBi |
Lemaigre, F., Peers, B., Lafontaine, D., Mathy-Hartert, M., Rousseau, G., Belayew, A., & Martial, J. (12 April 1989). Pituitary-specific factor binding to the human prolactin, growth hormone, and placental lactogen genes. DNA, 8 (3), 149-159. Peer Reviewed verified by ORBi |
Hooghe-Peters, E., Belayew, A., Herregodts, P., Velkeniers, B., smets, G., Martial, J., & Vanhaelst, L. (01 December 1988). Discrepancy between prolactin (PRL) messenger ribonucleic acid and PRL content in rat fetal pituitary cells: possible role of dopamine. Molecular Endocrinology, 2 (12), 1163-1168. Peer Reviewed verified by ORBi |
Davis, J., Belayew, A., & Sheppard, M. (12 November 1988). Prolactin and growth hormone. Bailliere's Clinical Endocrinology and Metabolism, 2 (4), 797-834. Peer Reviewed verified by ORBi |
Velkeniers, B., Hooghe-Peters, E., Hooghe, R., Belayew, A., smets, G., Claeys, M., Robberecht, P., & Vanhaelst, L. (12 September 1988). Prolactin cell subpopulations separated on discontinuous Percoll gradient: an immunocytochemical, biochemical, and physiological characterization. Endocrinology, 132 (3), 1619-1630. Peer Reviewed verified by ORBi |
Raipert, E., Lemaigre, F., Eliard, P., Place, M., Lafontaine, D., Economidis, I., Belayew, A., Martial, J., & Rousseau, G. (12 May 1987). Glucocorticoid receptors bound to the antagonist RU486 are not downregulated despite their capacity to interact in vitro with defined gene regions. Journal of Steroid Biochemistry, 26 (5), 513-520. Peer Reviewed verified by ORBi |
 | Barlow, J., Voz, M., Eliard, P., Mathy-Hartert, M., De Nayer, P., Economidis, I., Belayew, A., Martial, J., & Rousseau, G. (12 December 1986). Thyroid hormone receptors bind to defined regions of the growth hormone and placental lactogen genes. Proceedings of the National Academy of Sciences of the United States of America, 83 (23), 9021-9025. Peer Reviewed verified by ORBi |
Belayew, A., Bellefroid, E., Berwaer, M., Dumoulin, M., Lambert, C., Lemaitre-Wathy, C., Mathy-Hartert, M., Morin, A., Pasleau, F., & Scippo, M. (12 July 1986). Localization of transcription regulatory sequences. Application to the genes of the prolactin family. Annales d'Endocrinologie, 47 (1), 7-10. Peer Reviewed verified by ORBi |
Eliard, P., Marchand, M., Rousseau, G., Formstecher, P., Mathy-Hartert, M., Belayew, A., & Martial, J. (12 December 1985). Binding of the human glucocorticoid receptor to defined regions in the human growth hormone and placental lactogen genes. DNA, 4 (6), 409-417. Peer Reviewed verified by ORBi |
Pachnis, V., Belayew, A., & Tilghman, S. (12 July 1985). Studies into the raf and Rif genes in the mouse. Current Topics in Microbiology and Immunology, 122, 50-52. Peer Reviewed verified by ORBi |
 | Pachnis, V., Belayew, A., & Tilghman, S. (12 September 1984). Locus unlinked to alpha-fetoprotein under the control of the murine raf and Rif genes. Proceedings of the National Academy of Sciences of the United States of America, 81, 5523-5527. doi:10.1073/pnas.81.17.5523 Peer Reviewed verified by ORBi |
Belayew, A., & Martial, J. (12 June 1984). Genetic engineering and its applications. Journal de Pharmacie de Belgique, 39 (3), 185-200. Peer Reviewed verified by ORBi |
 | Truong, A., Duez, C., Belayew, A., Renard, A., Pictet, R., Bell, G., & Martial, J. (12 February 1984). Isolation and characterization of the human prolactin gene. EMBO Journal, 3 (2), 429-437. Peer Reviewed verified by ORBi |
 | Belayew, A., & Tilghman, S. (12 November 1982). Genetic analysis of alpha-fetoprotein synthesis in mice. Molecular and Cellular Biology, 2 (11), 1427-1435. Peer Reviewed verified by ORBi |
 | Tilghman, S., & Belayew, A. (12 September 1982). Transcriptional control of the murine albumin/alpha-fetoprotein locus during development. Proceedings of the National Academy of Sciences of the United States of America, 79 (17), 5254-5257. Peer Reviewed verified by ORBi |
 | Kaufmann, R., Belayew, A., Nusgens, B., Lapière, C., & Gielen, J. (12 May 1980). Extraction and translation of collagen mRNA from fetal calf skin. European Journal of Biochemistry, 106, 593-601. Peer Reviewed verified by ORBi |
Belayew, A. (12 May 1978). Proteins immunologically related to alpha-foetoprotein in the in vitro translation products of rat yolk sac mRNA [proceedings]. Archives Internationales de Physiologie et de Biochimie, 86 (2), 406-408. Peer Reviewed verified by ORBi |